Capillary and Venous Blood Sampling Devices Segmentation
Product Type (Capillary Blood Sampling Devices, Venous Blood Sampling Devices)
Venous blood sampling devices segment is expected to account for capillary and venous blood sampling devices market share of more than 58.6% by the end of 2037 due to an increased demand in usage across hospitals, laboratories, and diagnostic centers. While capillary sampling techniques have emerged as those that are faster and easier to perform, venous collection is still considered the most effective method for obtaining a wide range of blood parameters. In December 2024, BD and Babson Diagnostics advanced fingertip blood collection technologies to increase lab-quality testing with less use of the conventional method, venipuncture. This partnership demonstrates the continuous advancement in the blood collection process, stressing how the experience can be made as comfortable as possible for the patient.
Age Group (Pediatric, Adult, Geriatric)
In capillary and venous blood sampling devices market, adult segment is set to hold revenue share of over 64.6% by the end of 2037, given that adults are the largest population that requires frequent blood tests for chronic illnesses. The rising prevalence of diabetes, cardiovascular diseases, and metabolic disorders, among other diseases, necessitate repeated testing. In January 2025, OM Malaysia entered into an MOU with Diabetes Malaysia to increase the availability of diabetes care devices, with a focus on the increasing demand for blood sampling devices specifically for adults. This collaboration shows the global focus on controlling the increasing prevalence of chronic diseases and the need for effective diagnostic tests.
Our in-depth analysis of the global capillary and venous blood sampling devices market includes the following segments:
|
Product Type |
|
|
Age Group |
|
|
Test Type |
|
|
Application |
|
|
End user |
|
